FdaApplication

ANDA 219691

Back to search

Identifiers

Properties

PropertyValue
applicant_nameABON PHARMACEUTICALS LLC
application_typeANDA
approval_date2025-09-23

Products (2)

ProductActive ingredientStrengthDosage form
ERYTHROMYCINERYTHROMYCIN500MGTABLET;ORAL
ERYTHROMYCINERYTHROMYCIN250MGTABLET;ORAL

2 products